Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette M Staiger

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Virchows Archiv : an International Journal of Pathology|March 3, 2021
The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOSKatrin S Hüttl, Annette M Staiger, Julia Richter, et al.
Leukemia & Lymphoma|December 23, 2020
Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphomaCarmen Nordmo, Gunther Glehr, Michael Altenbuchinger, et al.
Journal of Visualized Experiments : Jove|September 29, 2025
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell LymphomaJulia Thiel, Jan A Schlegel, Sam Steinfeldt, et al.
British Journal of Haematology|October 7, 2021
Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational featuresJulia Richter, Katharina John, Annette M Staiger, et al.
International Journal of Molecular Sciences|December 11, 2025
Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse ModelsDina Mönch, Julia Thiel, Meng Dong, et al.
Genome Research|November 18, 2025
Integration of high-throughput proteomic data and complementary omics layers with PriOmicsRobin Kosch, Katharina Limm, Annette M Staiger, et al.
British Journal of Haematology|August 14, 2019
The impact of SOCS1 mutations in diffuse large B-cell lymphomaKevin Mellert, Melanie Martin, Jochen K Lennerz, et al.
Histopathology|November 9, 2020
Cytokeratin expression in plasmablastic lymphoma - a possible diagnostic pitfall in the routine work-up of tumoursKatrin S Huettl, Annette M Staiger, Heike Horn, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphomaMarco Fangazio, Erik Ladewig, Karen Gomez, et al.
The Lancet. Haematology|March 5, 2021
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trialFabian Frontzek, Marita Ziepert, Maike Nickelsen, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Virchows Archiv : an International Journal of Pathology|March 3, 2021
The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOSKatrin S Hüttl, Annette M Staiger, Julia Richter, et al.
Leukemia & Lymphoma|December 23, 2020
Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphomaCarmen Nordmo, Gunther Glehr, Michael Altenbuchinger, et al.
Journal of Visualized Experiments : Jove|September 29, 2025
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell LymphomaJulia Thiel, Jan A Schlegel, Sam Steinfeldt, et al.
British Journal of Haematology|October 7, 2021
Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational featuresJulia Richter, Katharina John, Annette M Staiger, et al.
International Journal of Molecular Sciences|December 11, 2025
Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse ModelsDina Mönch, Julia Thiel, Meng Dong, et al.
Genome Research|November 18, 2025
Integration of high-throughput proteomic data and complementary omics layers with PriOmicsRobin Kosch, Katharina Limm, Annette M Staiger, et al.
British Journal of Haematology|August 14, 2019
The impact of SOCS1 mutations in diffuse large B-cell lymphomaKevin Mellert, Melanie Martin, Jochen K Lennerz, et al.
Histopathology|November 9, 2020
Cytokeratin expression in plasmablastic lymphoma - a possible diagnostic pitfall in the routine work-up of tumoursKatrin S Huettl, Annette M Staiger, Heike Horn, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphomaMarco Fangazio, Erik Ladewig, Karen Gomez, et al.
The Lancet. Haematology|March 5, 2021
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trialFabian Frontzek, Marita Ziepert, Maike Nickelsen, et al.
Pageof 5